Aull & Monroe Investment Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $280K | Hold |
|
|||||
|
2025
Q2 | $249K | Sell |
|
|||||
|
2025
Q1 | $258K | Sell |
|
|||||
|
2024
Q4 | $241K | Sell |
|
|||||
|
2024
Q3 | $358K | Sell |
|
|||||
|
2024
Q2 | $359K | Sell |
|
|||||
|
2024
Q1 | $509K | Sell |
|
|||||
|
2023
Q4 | $456K | Sell |
|
|||||
|
2023
Q3 | $468K | Sell |
|
|||||
|
2023
Q2 | $462K | Hold |
|
|||||
|
2023
Q1 | $461K | Sell |
|
|||||
|
2022
Q4 | $464K | Sell |
|
|||||
|
2022
Q3 | $398K | Sell |
|
|||||
|
2022
Q2 | $753K | Hold |
|
|||||
|
2022
Q1 | $753K | Hold |
|
|||||
|
2021
Q4 | $763K | Sell |
|
|||||
|
2021
Q3 | $680K | Hold |
|
|||||
|
2021
Q2 | $709K | Sell |
|
|||||
|
2021
Q1 | $668K | Sell |
|
|||||
|
2020
Q4 | $714K | Sell |
|
|||||
|
2020
Q3 | $779K | Sell |
|
|||||
|
2020
Q2 | $873K | Sell |
|
|||||
|
2020
Q1 | $838K | Sell |
|
|||||
|
2019
Q4 | $1.04M | Hold |
|
|||||
|
2019
Q3 | $946K | Sell |
|
|||||
|
2019
Q2 | $891K | Buy |
|
|||||
|
2019
Q1 | $877K | Sell |
|
|||||
|
2018
Q4 | $840K | Sell |
|
|||||
|
2018
Q3 | $963K | Buy |
|
|||||
|
2018
Q2 | $959K | Buy |
|
|||||
|
2018
Q1 | $900K | Buy |
|
|||||
|
2017
Q4 | $809K | Sell |
|
|||||
|
2017
Q3 | $1.03M | Hold |
|
|||||
|
2017
Q2 | $1.09M | Hold |
|
|||||
|
2017
Q1 | $1.07M | Buy |
|
|||||
|
2016
Q4 | $949K | Sell |
|
|||||
|
2016
Q3 | $1.07M | Sell |
|
|||||
|
2016
Q2 | $1.09M | Buy |
|
|||||
|
2016
Q1 | $1.02M | Buy |
|
|||||
|
2015
Q4 | $965K | Buy |
|
|||||
|
2015
Q3 | $883K | Sell |
|
|||||
|
2015
Q2 | $999K | Buy |
|
|||||
|
2015
Q1 | $975K | Buy |
|
|||||
|
2014
Q4 | $757K | Buy |
|
|||||
|
2014
Q3 | $721K | Buy |
|